Advertisement

Picture Excelya CRO Your Trial Across Europe 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3061 | Ordered by Date (descending)
1 2 3 ... 29 30 31  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Innovative Molecules–Akampion: public relations, 202106 service existent by Akampion 2021-06-07
Innovative Molecules–Life Sciences Partners: investment, 202106 financing round Series A totalling €20m incl lead investor LSP 2021-06-07
Innovative Molecules–SEVERAL: investment, 202106 financing round Series A €20m led by LSP 2021-06-07
AstraZeneca–Celonis: management execution software, 202106 supply existent customer AstraZeneca 2021-06-02
Celonis–Arena Holdings: investment, 202106 financing round Series D totalling $1b incl existing + co-investor Arena Holdings 2021-06-02
Celonis–Durable Capital: investment, 202106 financing round Series D totalling $1b incl new + co-lead investor Durable Capital Partners LP 2021-06-02
Celonis–Franklin Templeton: investment, 202106 financing round Series D totalling $1b incl new + co-investor Franklin Templeton 2021-06-02
Celonis–SEVERAL: investment, 202106 financing round Series D $1b co-led by Durable Capital Partners + T Rowe Price 2021-06-02
Celonis–Splunk Ventures: investment, 202106 financing round Series D totalling $1b incl new + co-investor Splunk Ventures 2021-06-02
Celonis–T Rowe Price: investment, 202106 financing round Series D totalling $1b incl new + co-lead investor funds+accounts managed by T Rowe Price 2021-06-02
Constellation–Centerview Partners: financial services, 202106 supply service Centerview Partners is financial advisor for acquisition by MorphoSys 2021-06-02
Constellation–MorphoSys: investment, 202106– acquisition cash tender offer $1.7b at $34/share by MorphoSys 2021-06-02
Constellation–Wachtell Lipton: legal services, 202106 supply service Wachtell Lipton is legal advisor regarding acquisition by MorphoSys 2021-06-02
Danaher–Celonis: management execution software, 202106 supply existent customer Danaher Corp 2021-06-02
Gilde Investment–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media contact for Gilde Healthcare 2021-06-02
GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva 2021-06-02
GSK–Celonis: management execution software, 202106 supply existent customer GSK 2021-06-02
L’Oréal–Celonis: management execution software, 202106 supply existent customer L’Oréal 2021-06-02
MorphoSys–Goldman Sachs: financial services, 202106 supply service GS Bank Europe SA is financial advisor with regard to acquisition of Constellation 2021-06-02
MorphoSys–Royalty Pharma: credit, 202106– up to $350m development funding bonds over 1-year period 2021-06-02
MorphoSys–Royalty Pharma: investment, 202106– optional $100m investment via capital increase excl subscription rights 2021-06-02
MorphoSys–Skadden Arps: legal services, 202106 supply service Skadden Arps Slate Meagher & Flom is legal advisor for acquisition of Constellation 2021-06-02
Pfizer–Celonis: management execution software, 202106 supply existent customer Pfizer 2021-06-02
Royalty Pharma–Goodwin Procter: legal services, 202106 supply service Goodwin is legal advisor regarding royalty + licensing agreem with MorphoSys 2021-06-02
Royalty Pharma–MorphoSys: guselkumab + otilimab et al, 202106– acquisition royalty/milestone rights $1.425b upfront + $150m milestones by Royalty 2021-06-02
Siemens–Celonis: management execution software, 202106 supply existent customer Siemens 2021-06-02
Inovedis–High-Tech Gründerfonds: investment, 202106 seed financing round totalling €1.8m incl lead investor HTGF 2021-06-01
Inovedis–SEVERAL: investment, 202106 seed financing round €1.8m led by HTGF 2021-06-01
Ada Health–Bayer: investment, 202105 financing round Series B totalling $90m incl lead investor Leaps by Bayer 2021-05-27
Ada Health–F4: investment, 202105 financing round Series B totalling $90m incl co-investor F4 2021-05-27
Ada Health–Inteligo Bank: investment, 202105 financing round Series B totalling $90m incl co-investor Inteligo Bank 2021-05-27
Ada Health–Mutschler Ventures: investment, 202105 financing round Series B totalling $90m incl co-investor Mutschler Ventures 2021-05-27
Ada Health–Samsung: investment, 202105 financing round Series B totalling $90m incl co-investor Samsung Catalyst Fund 2021-05-27
Ada Health–SEVERAL: investment, 202105 financing round Series B $90m led by Leaps by Bayer 2021-05-27
Ada Health–Vitruvian Partners: investment, 202105 financing round Series B totalling $90m incl co-investor Vitruvian Partners 2021-05-27
Origin.bio–Acequia Capital: investment, 202105 financing round totalling $15m incl new + co-investor Acequia Capital 2021-05-26
Origin.bio–BY Capital: investment, 202105 financing round totalling $15m incl existing + co-investor BlueYard Capital 2021-05-26
Origin.bio–EQT: investment, 202105 financing round totalling $15m incl lead investor EQT Ventures 2021-05-26
Origin.bio–Inventures: investment, 202105 financing round totalling $15m incl new + co-investor Inventures 2021-05-26
Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Charlie Songhurst 2021-05-26
Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Sten Tamkivi 2021-05-26
Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Taavet Hinrikus 2021-05-26
Origin.bio–SEVERAL: investment, 202105 financing round $15m led by EQT Ventures 2021-05-26
Haya Therapeutics–4See Ventures: investment, 202105 seed financing round totalling CHF18m incl co-investor 4See Ventures 2021-05-20
Haya Therapeutics–Apollo Ventures: investment, 202105 seed financing round totalling CHF18m incl co-investor Apollo Health Ventures 2021-05-20
Haya Therapeutics–Bernina BioInvest: investment, 202105 seed financing round totalling CHF18m incl co-investor Bernina BioInvest 2021-05-20
Haya Therapeutics–Bioscribe: public relations, 202105 service existent by Bioscribe 2021-05-20
Haya Therapeutics–Broadview Ventures: investment, 202105 seed financing round totalling CHF18m incl lead investor Broadview Ventures 2021-05-20
Haya Therapeutics–Schroders: investment, 202105 seed financing round totalling CHF18m incl co-investor Schroder Adveq 2021-05-20
Haya Therapeutics–SEVERAL: investment, 202105 seed financing round CHF18m led by Broadview Ventures 2021-05-20
Haya Therapeutics–Univ Lausanne: RNA-targeting drug, 202105 license excl existent for lncRNA Wisper targeting drug from CHUV 2021-05-20
Haya Therapeutics–Viva Biotech: investment, 202105 seed financing round totalling CHF18m incl co-investor Viva BioInnovator 2021-05-20
Numab–BlackRock: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor funds/accounts managed by BlackRock 2021-05-20
Numab–BVF Partners: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor BVF Partners LP 2021-05-20
Numab–Cormorant Asset Management: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor Cormorant AM 2021-05-20
Numab–Forbion: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor Forbion Growth Opportunities Fund 2021-05-20
Numab–HBM: investment, 202105 financing round Series C totalling CHF100m incl new + co-lead investor HBM Partners 2021-05-20
Numab–Novo Group: investment, 202105 financing round Series C totalling CHF100m incl new + co-lead investor Novo Holdings 2021-05-20
Numab–Octagon Capital: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor Octagon Capital Advisors 2021-05-20
Numab–RTW Investments: investment, 202105 financing round Series C totalling CHF100m incl new + co-investor RTW investments LP 2021-05-20
Numab–SEVERAL: investment, 202105 financing round Series C CHF100m co-led by new investors Novo Holdings + HBM Partners 2021-05-20
Swixx Biopharma–HBM: investment, 202105– capital increase totalling €45m incl €5m from existing investor HBM Healthcare Investments 2021-05-20
Swixx Biopharma–Mérieux: investment, 202105– capital increase totalling €45m incl €40m for minority share from new investor MxEP 2021-05-20
Swixx Biopharma–SEVERAL: investment, 202105– capital increase €45m with €40m from new investor MxEP + €5m from existing investor HBM 2021-05-20
Nanoscribe–Cellink: investment, 202105– acquisition 100% of Nanoscribe Holding GmbH €22m upfront cash + €12m in Series B shares + €16m milestones cash 2021-05-19
Hummingbird Bioscience–Bellevue: investment, 202105 financing round Series C totalling $125m incl new + co-investor Pureos Bioventures 2021-05-18
Hummingbird Bioscience–SEVERAL: investment, 202105 financing round Series C $125m led by Novo Holdings 2021-05-18
Immunodiagnostic Systems–PerkinElmer: investment, 202105– recommended all cash offer £110m by PerkinElmer ANNOUNCED 2021-05-17
Biocatalysts Ltd–BRAIN Biotech: investment, 202105 acquisition addit 16.7% for £3.9m bringing total to 82.2% with 2 put options excercised 2021-05-12
AMSilk–Cargill: investment, 202105 financing round Series C totalling €29m incl new + co-investor Cargill 2021-05-11
AMSilk–ER Capital Holdings: investment, 202105 financing round Series C totalling €29m incl new + co-investor ER Capital Holdings 2021-05-11
AMSilk–MIG Fonds: investment, 202105 financing round Series C totalling €29m incl existing + co-investor MIG Verwaltungs AG 2021-05-11
AMSilk–Novo Group: investment, 202105 financing round Series C totalling €29m incl new + lead investor Novo Growth 2021-05-11
AMSilk–SEVERAL: investment, 202105 financing round Series C €29m led by Novo Growth with Cargill + ER Capital Holdings + MIG AG + Athos KG 2021-05-11
AMSilk–Strüngmann Group: investment, 202105 financing round Series C totalling €29m incl existing + co-investor Athos KG 2021-05-11
Cellares–SEVERAL: investment, 202105 financing round Series B $82m led by Decheng Capital + Eclipse Ventures 2021-05-05
Cellares–Skyviews Life Science: investment, 202105 financing round Series B totalling $82m incl new + co-investor Skyviews Life Science 2021-05-05
Cytoki Pharma–+ND Capital: investment, 202105 financing round Series A totalling $45m incl co-investor +ND Captial 2021-05-05
Cytoki Pharma–SEVERAL: investment, 202105 financing round Series A $45m led by existing investor Lundbeckfonden Emerge 2021-05-05
Cytoki Pharma–Ysios Capital: investment, 202105 financing round Series A totalling $45m incl co-investor Ysios Capital 2021-05-05
APR Applied Pharma Research–Relief Therapeutics: investment, 202105– acquisition for CHF22m cash + CHF50m in shares binding term sheet signed 2021-05-04
Labforward–SEVERAL: investment, 202105 financing round Series B 2nd closing >€3m led by Fielmann Family Office bringing total Series B to >€8.5m 2021-05-04
Oculis–BVCF Management: investment, 202105 financing round Series C totalling $57m incl new + co-lead investor BVCF Management 2021-05-04
Oculis–Hyfinity Investments: investment, 202105 financing round Series C totalling $57m incl new + co-lead investor Hyfinity Investments 2021-05-04
Oculis–SEVERAL: investment, 202105 financing round Series C $57m co-led by new investors BVCF Management + Hyfinity Investments 2021-05-04
Aquila Biolabs–Scientific Industries: investment, 202104 acquisition of Aquila Biolabs GmbH by Scientific Bioprocessing Inc 2021-04-30
Valneva–SEVERAL: investment, 202104– European private placement ANNOUNCED 2021-04-29
Valneva–SEVERAL: investment, 202104– US IPO of ADSs at Nasdaq Global Market ANNOUNCED 2021-04-29
Kaia Health–3VC: investment, 202104 financing round Series C totalling $75m incl existing + co-investor 3VC 2021-04-28
Kaia Health–A Round Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor A Round Capital 2021-04-28
Kaia Health–Balderton Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Balderton Capital 2021-04-28
Kaia Health–Eurazeo: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Eurazeo 2021-04-28
Kaia Health–Heartcore Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Heartcore Capital 2021-04-28
Kaia Health–Hot Cherry PR: public relations, 202104 service existent by Hot Cherry PR 2021-04-28
Kaia Health–OTHER: investment, 202104 financing round Series C totalling $75m incl undisclosed growth equity fund as lead investor 2021-04-28
Kaia Health–SEVERAL: investment, 202104 financing round Series C $75m led by undisclosed growth equity fund 2021-04-28
Kaia Health–Symphony Ventures: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Symphony Ventures 2021-04-28
Kaia Health–UnitedHealth: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Optum Ventures 2021-04-28
Exciva–Andera Partners: investment, 202104 existent investment of Andera Partners 2021-04-27
PreComb Therapeutics–FiveT Capital: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor FiveT Capital 2021-04-26
1 2 3 ... 29 30 31  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Excelya CRO We Care for Your Clinical Trials 650x80px

» top